Skip Nav Destination
Article navigation
Meeting Abstracts|
September 1991
IDENTIFICATION OF DNA MUTATIONS RESPONSIBLE FOR SERUM BUTYRYLCHOLINESTERASE VARIANTS WILL PERMIT A BETTER DIFFERENTIATION OF ABERRANT DRUG RESPONSES
Department of Anesthesiology, University of Michigan, Ann Arbor, MI 48109–0572
Anesthesiology September 1991, Vol. 75, A372.
Citation
B N La Du, S Primo-Parmo, AFL van der Spek; IDENTIFICATION OF DNA MUTATIONS RESPONSIBLE FOR SERUM BUTYRYLCHOLINESTERASE VARIANTS WILL PERMIT A BETTER DIFFERENTIATION OF ABERRANT DRUG RESPONSES. Anesthesiology 1991; 75:A372 doi: https://doi.org/10.1097/00000542-199109001-00372
Download citation file:
154
Views
Citing articles via
Most Viewed
Related Articles
Response to Mivacurium in a Patient Compound Heterozygous for a Novel and a Known Silent Mutation in the Butyrylcholinesterase Gene: Genotyping by Sequencing
Anesthesiology (September 2001)
Genotyping the Butyrylcholinesterase in Patients with Prolonged Neuromuscular Block after Succinylcholine
Anesthesiology (March 2005)
Methadone Pharmacogenetics: CYP2B6 Polymorphisms Determine Plasma Concentrations, Clearance, and Metabolism
Anesthesiology (November 2015)
Intraoperative Non–Record-keeping Usage of Anesthesia Information Management System Workstations and Associated Hemodynamic Variability and Aberrancies
Anesthesiology (December 2012)
Response to Mivacurium in Patients Carrying the K Variant in the Butyrylcholinesterase Gene
Anesthesiology (March 2005)
